BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21496834)

  • 21. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma.
    Schmidt LS
    Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.
    Toro JR; Glenn G; Duray P; Darling T; Weirich G; Zbar B; Linehan M; Turner ML
    Arch Dermatol; 1999 Oct; 135(10):1195-202. PubMed ID: 10522666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
    Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
    Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Sääf A; Zickert P; Aly M; Bergerheim U; Nordenskjöld M; Gad S; Giraud S; Denoux Y; Yonneau L; Méjean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
    BMC Med Genomics; 2010 Dec; 3():59. PubMed ID: 21162720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.
    Pradella LM; Lang M; Kurelac I; Mariani E; Guerra F; Zuntini R; Tallini G; MacKay A; Reis-Filho JS; Seri M; Turchetti D; Gasparre G
    Eur J Hum Genet; 2013 Oct; 21(10):1169-72. PubMed ID: 23386036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
    Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
    Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of renal tumors associated with Birt-Hogg-Dubé syndrome with focus on clinical and pathobiological aspects.
    Kuroda N; Furuya M; Nagashima Y; Gotohda H; Kawakami F; Moritani S; Ota S; Hora M; Michal M; Hes O; Nakatani Y
    Pol J Pathol; 2014 Jun; 65(2):93-9. PubMed ID: 25119168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.
    Schneider M; Dinkelborg K; Xiao X; Chan-Smutko G; Hruska K; Huang D; Sagar P; Harisinghani M; Iliopoulos O
    Fam Cancer; 2018 Jan; 17(1):135-139. PubMed ID: 28623476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
    Furuya M; Nakatani Y
    Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney cancer characteristics and genotype-phenotype-correlations in Birt-Hogg-Dubé syndrome.
    Sattler EC; Reithmair M; Steinlein OK
    PLoS One; 2018; 13(12):e0209504. PubMed ID: 30586397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple/bilateral renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Fahmy W; Safwat AS; Bissada NK; Curry N; Guirguis N; Clarke HS; Fraig M; Finkbeiner A
    Int Urol Nephrol; 2007; 39(4):995-9. PubMed ID: 17211573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel heterozygous mutation in the Birt-Hogg-Dubé Syndrome.
    Gómez Rivas J; Carrión DM; Alonso Y Gregorio S; Álvarez-Maestro M; Tabernero Gómez Á; Cisneros Ledo J
    Arch Esp Urol; 2017 Sep; 70(7):675-678. PubMed ID: 28891800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome.
    Kuroda N; Furuya M; Nagashima Y; Gotohda H; Moritani S; Kawakami F; Imamura Y; Bando Y; Takahashi M; Kanayama HO; Ota S; Michal M; Hes O; Nakatani Y
    Ann Diagn Pathol; 2014 Jun; 18(3):171-6. PubMed ID: 24767893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytologic and histologic findings in multiple renal hybrid oncocytic tumors in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Adley BP; Schafernak KT; Yeldandi AV; Yang XJ; Nayar R
    Acta Cytol; 2006; 50(5):584-8. PubMed ID: 17017453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.
    Wang XM; Mannan R; Zhang Y; Chinnaiyan A; Rangaswamy R; Chugh S; Su F; Cao X; Wang R; Skala SL; Hafez KS; Vaishampayan U; Mckenney J; Picken MM; Gupta S; Alaghehbandan R; Tretiakova M; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2024 Feb; 48(2):163-173. PubMed ID: 37994665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case of bilateral and multifocal renal cell carcinoma associated with Birt-Hogg-Dubé syndrome.
    Yamada Y; Sakamoto S; Furuya M; Nihei N; Nakatani Y; Ichikawa T
    Int J Urol; 2015 Feb; 22(2):230-1. PubMed ID: 25351926
    [No Abstract]   [Full Text] [Related]  

  • 37. Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?
    Johannesma PC; Houweling AC; Menko FH; van de Beek I; Reinhard R; Gille JJ; van Waesberghe JT; Thunnissen E; Starink TM; Postmus PE; van Moorselaar RJ
    Fam Cancer; 2016 Apr; 15(2):297-300. PubMed ID: 26603437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.
    Vocke CD; Fleming LR; Piskorski AM; Amin A; Phornphutkul C; de la Monte S; Vilboux T; Duncan F; Pellegrino J; Braddock B; Middelton LA; Schmidt LS; Merino MJ; Cowen EW; Introne WJ; Linehan WM; Smith ACM
    Am J Med Genet A; 2023 Feb; 191(2):490-497. PubMed ID: 36513625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FLCN gene-mutated renal cell neoplasms: mother and daughter cases with a novel germline mutation.
    Nagashima Y; Furuya M; Gotohda H; Takagi S; Hes O; Michal M; Grossmann P; Tanaka R; Nakatani Y; Kuroda N
    Int J Urol; 2012 May; 19(5):468-70. PubMed ID: 22211584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.
    Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR
    Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.